TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

Clinical trial NCT03829436 · COMPLETED

Trial details

NCT number: NCT03829436
Sponsor: Tempest Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Metastatic Castration Resistant Prostate Cancer Renal Cell Carcinoma Non-small Cell Lung Cancer Colorectal Cancer Squamous Cell Carcinoma of Head and Neck Triple-Negative Breast Cancer Urothelial Carcinoma Cholangiocarcinoma GastroEsophageal Cancer Pancreatic Cancer Sarcoma

Start date: 2019-03-20
Primary completion: 2022-09-07
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.